@ihv-umaryland.bsky.social researcher Dr. Sarah Kattakuzhy is exploring how GLP-1 agonists might treat cocaine use disorder — a potential breakthrough backed by NIH.
🎥 Watch the clip: #BreakthroughsCantWaitUMB #ScienceMatters
@ihv-umaryland.bsky.social researcher Dr. Sarah Kattakuzhy is exploring how GLP-1 agonists might treat cocaine use disorder — a potential breakthrough backed by NIH.
🎥 Watch the clip: #BreakthroughsCantWaitUMB #ScienceMatters